Financial Metrics Check: Checkpoint Therapeutics Inc (CKPT)’s Ratios for Trailing Twelve Months

The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

As of close of business last night, Checkpoint Therapeutics Inc’s stock clocked out at $3.43, down -9.26% from its previous closing price of $3.78. In other words, the price has decreased by -$9.26 from its previous closing price. On the day, 1.02 million shares were traded. CKPT stock price reached its highest trading level at $3.93 during the session, while it also had its lowest trading level at $3.41.

Ratios:

To gain a deeper understanding of CKPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 0.29 and its Current Ratio is at 0.29.

On June 09, 2021, B. Riley Securities started tracking the stock assigning a Buy rating and target price of $18.

On January 20, 2021, Cantor Fitzgerald started tracking the stock assigning a Overweight rating and target price of $16.Cantor Fitzgerald initiated its Overweight rating on January 20, 2021, with a $16 target price.

Insider Transactions:

Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Jun 26 ’24 when Oliviero James F III sold 24,610 shares for $2.05 per share. The transaction valued at 50,450 led to the insider holds 1,977,170 shares of the business.

GRAY WILLIAM GARRETT sold 13,038 shares of CKPT for $26,858 on Jun 26 ’24. The Chief Financial Officer now owns 672,186 shares after completing the transaction at $2.06 per share. On Feb 28 ’24, another insider, Oliviero James F III, who serves as the CEO, President and Director of the company, sold 5,894 shares for $2.06 each. As a result, the insider received 12,142 and left with 350,836 shares of the company.

Valuation Measures:

Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CKPT now has a Market Capitalization of 167495472 and an Enterprise Value of 150360544. For the stock, the TTM Price-to-Sale (P/S) ratio is 3039.81. Its current Enterprise Value per Revenue stands at 1927.699.

Stock Price History:

Over the past 52 weeks, CKPT has reached a high of $3.97, while it has fallen to a 52-week low of $1.36. The 50-Day Moving Average of the stock is 21.77%, while the 200-Day Moving Average is calculated to be 55.06%.

Shares Statistics:

It appears that CKPT traded 640.05K shares on average per day over the past three months and 826170 shares per day over the past ten days. A total of 48.83M shares are outstanding, with a floating share count of 40.57M. Insiders hold about 16.91% of the company’s shares, while institutions hold 16.18% stake in the company. Shares short for CKPT as of 1730332800 were 5563543 with a Short Ratio of 8.69, compared to 1727654400 on 4375843. Therefore, it implies a Short% of Shares Outstanding of 5563543 and a Short% of Float of 13.370000000000001.

Most Popular